Buscar
Mostrando ítems 1-4 de 4
Artículo
Artículo
Artículo
Artículo
Initial experience with golimumab in clinical practice for ulcerative colitis
(Aran Ediciones S.A., 2016)
Background: Golimumab is a TNF-blocking agent indicated as a second-line therapy in ulcerative colitis. Purpose: To research the effectiveness and safety of golimumab in patients with ulcerative colitis in clinical ...